DeepMind launches a 27 billion parameter model for single-cell analysis, aiding cancer therapy research.
Why it matters
This development represents a significant advancement in AI applications in healthcare, particularly in cancer research. The ability to analyze single cells at such a scale can lead to breakthroughs in understanding cancer mechanisms and developing targeted therapies, showcasing the potential of AI in transforming medical research and treatment strategies.
DeepMind created a powerful AI model that helps scientists study individual cells to find new ways to treat cancer. This could lead to better cancer therapies in the future.
OpenAI is shifting focus from consumer-facing 'moonshots' like Sora to enterprise AI, with key personnel departures and team consolidations.
Read on TechCrunch →Zoom partners with Sam Altman's World to implement human ID verification in meetings, aiming to combat AI-generated imposters.
Read on TechCrunch →Anthropic has launched Claude Design, a new AI-powered product aimed at helping non-designers like founders and product managers quickly create visuals to share their ideas.
Read on TechCrunch →